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Environmental contamination may play a major role in
intensive care unit (ICU)-acquired infections, despite
current terminal cleaning standards [1]. Anderson et al.
[2] recently performed the first large randomized trial
investigating a no-touch method of terminal cleaning
with a patient-centred outcome, and provided more ro-
bust data on the role of environmental contamination
for healthcare-associated infections. The authors evalu-
ated three different enhanced terminal disinfection
methods (ultraviolet, UV light, UV light plus bleach, and
bleach) compared to the reference standard for preven-
tion of transmission of multidrug resistant organisms
(MDROs) and Clostridium difficile to patients exposed
to a room whose prior occupant was either colonized or
infected with a MDRO.
The addition of UV light to the reference disinfection
strategy (based on quaternary ammonium) reduced the
transmission of the targeted MDROs (methicillin-resist-
ant Staphylococcus aureus and vancomycin-resistant en-
terococci) by 30%, while no significant difference was
observed when UV light was compared to bleach or to
the combination of bleach and UV. Moreover, the au-
thors did not observe a difference in colonization and
infection by C. difficile when UV light was added to
bleach (the standard disinfection method for C. difficile).
We agree with them that this would represent the mini-
mum effect of the UV strategy and that, in a real-life
scenario with considerably less cleaning compliance,
the benefit from UV-based enhanced terminal clean-
ing would have been more incisive. Notably, killing of
C. difficile spores appeared to be time- and dose-
dependent in a previously published study [3].
ICU-acquired infections are a major health problem
worldwide [4]. Environmental contamination may pose
an even higher challenge in this setting due to a number
of factors: a higher prevalence of colonization and infec-
tion by MDROs, understaffing, the presence of sophisti-
cated equipment with high-touch surfaces and specific
cleaning procedures [1]. The benefit of no-touch
methods for terminal cleaning may be theoretically
higher in these circumstances. Unfortunately, the study
did not provide data on Acinetobacter since only one
exposed patient acquired this organism. The role of
Gram-negative bacteria may be more relevant in the
ICUs. In a meta-analysis of studies investigating the risk
of acquiring bacteria from prior bed occupants, the odds
ratio for acquisition of Acinetobacter was the highest,
corresponding to 4.91 (95% CI 2.79–8.64) [5]. The study
by Anderson et al. highlights how terminal cleaning may
be considered the basis to build an effective strategy to
reduce healthcare-associated infections.
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